In this long-term study, we found that patients with high fasting plasma glucose (FPG) and insulin requirement during pregnancy are at an increased risk of developing T2DM, while pregestational obesity is predictive of progression to MetS. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.